BrightGene Bio-Medical Technology Co Ltd
SSE:688166

Watchlist Manager
BrightGene Bio-Medical Technology Co Ltd Logo
BrightGene Bio-Medical Technology Co Ltd
SSE:688166
Watchlist
Price: 31.54 CNY 2.1% Market Closed
Market Cap: 13.3B CNY
Have any thoughts about
BrightGene Bio-Medical Technology Co Ltd?
Write Note

DCF Value

This DCF valuation model was created by Alpha Spread and was last updated on Nov 27, 2024.

Estimated DCF Value of one 688166 stock is 15.55 CNY. Compared to the current market price of 31.54 CNY, the stock is Overvalued by 51%.

DCF Value
Base Case
15.55 CNY
Overvaluation 51%
DCF Value
Price
Worst Case
Base Case
Best Case
15.55
DCF Value
Worst Case
Base Case
Best Case
Hide
DCF Value: 15.55 CNY

Present Value Calculation

This block is the starting point of the DCF valuation process. It calculates the present value of a company's forecasted cash flows based on selected operating model. Adjust key parameters like discount rate and terminal growth, and alter inputs such as revenue growth and margins to see their impact on valuation.

DCF Model
Base Case Scenario

The present value of cash flows over the next 5 years amounts to 1.3B CNY. The present value of the terminal value is 5.3B CNY. The total present value equals 6.6B CNY.
Forecast Period
Years
Discount Rate
%
Show All DCF Settings
Terminal Growth
%
Hide DCF Settings
Save

DCF Value Calculation

This stage translates the present value into DCF value per share. For firm valuation models, it adjusts present value for debt and assets to derive equity value (skipped if using equity valuation model). Finally, this equity value is divided by the number of shares to determine the DCF value per share.

Present Value to DCF Value
Capital Structure

Present Value 6.6B CNY
Equity Value 6.6B CNY
/ Shares Outstanding 422.5m
688166 DCF Value 15.55 CNY
Overvalued by 51%

You are using the equity valuation model. In this approach, further calculations for converting firm value to equity value are not required. The present value, obtained in the present value calculation block, already represents the equity value.

The DCF value per share is derived by dividing the present value by the number of shares:

Present Value
6.6B CNY
/
Number of Shares
422.5m
=
DCF Value
15.55 CNY

Valuation Analysis

Sensitivity Analysis
DCF Value Sensitivity Analysis

Sensitivity Analysis assesses how changes in key factors like revenue growth, margin, and discount rate affect a stock's DCF value. By visualizing various scenarios, from significant downturns to optimistic growth, this tool helps you understand potential valuation shifts, aiding in risk assessment and strategic decision-making.

DCF Financials
Financials used in DCF Calculation

Revenue
1.3B 2.3B
Net Income
216m 400.2m

See Also

Discover More

What is the DCF value of one 688166 stock?

Estimated DCF Value of one 688166 stock is 15.55 CNY. Compared to the current market price of 31.54 CNY, the stock is Overvalued by 51%.

The true DCF Value lies somewhere between the worst-case and best-case scenario values. This is because the future is not predetermined, and the stock's DCF Value is based almost entirely on the future of the company. Knowing the full range of possible stock DCF values gives a complete picture of the investment risks and opportunities.

How was the DCF Value calculated?

1. Present Value Calculation. Utilizing the DCF operating model, BrightGene Bio-Medical Technology Co Ltd's future cash flows are projected and then discounted using a chosen discount rate to determine its Present Value, which is calculated at 6.6B CNY.

2. DCF Value Calculation. The company's capital structure is employed to derive the total Equity Value from the previously calculated Present Value of the cash flow. This Equity Value, when divided by the total number of outstanding shares, yields the DCF Value of 15.55 CNY per share.

Back to Top
//